Opportunities for use of human iPS cells in predictive toxicology
about
Differentiation of human embryonic stem cells and induced pluripotent stem cells to cardiomyocytes: a methods overviewAn Engineered N-Cadherin Substrate for Differentiation, Survival, and Selection of Pluripotent Stem Cell-Derived Neural ProgenitorsTranslational Prospects and Challenges in Human Induced Pluripotent Stem Cell Research in Drug DiscoveryLong non-coding RNAs as surrogate indicators for chemical stress responses in human-induced pluripotent stem cellsPrediction of developmental chemical toxicity based on gene networks of human embryonic stem cellsDrug-induced liver injury: recent advances in diagnosis and risk assessment.Examining the protective role of ErbB2 modulation in human-induced pluripotent stem cell-derived cardiomyocytes.Comparison of electrophysiological data from human-induced pluripotent stem cell-derived cardiomyocytes to functional preclinical safety assays.In vitro cardiotoxicity assessment of environmental chemicals using an organotypic human induced pluripotent stem cell-derived model.New iPSC for old long QT syndrome modeling: putting the evidence into perspective.High purity human-induced pluripotent stem cell-derived cardiomyocytes: electrophysiological properties of action potentials and ionic currents.Multiparameter in vitro assessment of compound effects on cardiomyocyte physiology using iPSC cells.iPS cell-derived cardiogenicity is hindered by sustained integration of reprogramming transgenesAssessment of beating parameters in human induced pluripotent stem cells enables quantitative in vitro screening for cardiotoxicityHigh-content assays for hepatotoxicity using induced pluripotent stem cell-derived cellsNovel application of human neurons derived from induced pluripotent stem cells for highly sensitive botulinum neurotoxin detectionThe adverse effects of air pollution on the nervous system.The potential of induced pluripotent stem cells as a translational model for neurotoxicological riskElectrical and Mechanical Strategies to Enable Cardiac Repair and Regeneration.The effects of jaspamide on human cardiomyocyte function and cardiac ion channel activityExtracellular Matrix-Mediated Maturation of Human Pluripotent Stem Cell-Derived Cardiac Monolayer Structure and Electrophysiological Function.Ductular reaction-on-a-chip: Microfluidic co-cultures to study stem cell fate selection during liver injury.Prediction of Differentiation Tendency Toward Hepatocytes from Gene Expression in Undifferentiated Human Pluripotent Stem Cells.Comparison of a teratogenic transcriptome-based predictive test based on human embryonic versus inducible pluripotent stem cells.The utility of patient specific induced pluripotent stem cells for the modelling of Autistic Spectrum Disorders.Cellular reprogramming: a new technology frontier in pharmaceutical research.Genetics of congenital and drug-induced long QT syndromes: current evidence and future research perspectives.Induced pluripotent stem cells for post-myocardial infarction repair: remarkable opportunities and challenges.Competency of different cell models to predict human hepatotoxic drugs.Concise Review: Liver Regenerative Medicine: From Hepatocyte Transplantation to Bioartificial Livers and Bioengineered Grafts.Toxicity testing and drug screening using iPSC-derived hepatocytes, cardiomyocytes, and neural cells.Human hepatocytes derived from pluripotent stem cells: a promising cell model for drug hepatotoxicity screening.Human-induced pluripotent stem cell-derived cardiomyocytes exhibit temporal changes in phenotype.A Human Induced Pluripotent Stem Cell-Derived Cardiomyocyte (hiPSC-CM) Multielectrode Array Assay for Preclinical Cardiac Electrophysiology Safety Screening.Identification of genomic biomarkers for anthracycline-induced cardiotoxicity in human iPSC-derived cardiomyocytes: an in vitro repeated exposure toxicity approach for safety assessment.Monocyte-derived hepatocyte-like cells for causality assessment of idiosyncratic drug-induced liver injury.Phenotypic Characterization of Toxic Compound Effects on Liver Spheroids Derived from iPSC Using Confocal Imaging and Three-Dimensional Image Analysis.Identification of RNA biomarkers for chemical safety screening in mouse embryonic stem cells using RNA deep sequencing analysisPut to the testMicropatterning Facilitates the Long-Term Growth and Analysis of iPSC-Derived Individual Human Neurons and Neuronal Networks.
P2860
Q24618089-3EAF2C9B-6109-425B-B014-8B1E8BAA95A8Q27300806-992369C4-9C5E-481B-A287-0AE3406C5716Q28072402-EB60C197-1DC4-43B5-923C-C1CFB09C6C99Q28542672-44604E93-E693-495B-B204-72DE9F98603CQ28831020-BD7C05CC-0AC5-4816-A22C-4A7C2D4FD9D6Q30235089-F08679B7-6FD1-4881-904D-41CC0998619BQ30593372-58822A7E-A13D-42BB-9D24-82768394DAFAQ30629611-1019F6DB-E2D5-4A25-BF60-2CFA409CF37CQ32181083-5CBBF992-2165-4678-AC9E-DCC228E30753Q33163663-DCE94C89-384A-4DDA-9180-B3DFBD5B4487Q34213428-9A352362-6AF1-45B4-B7E9-06ACDC290CB9Q34299468-377706DE-91D7-49A7-B483-46705C4E4DA5Q34756386-883E58DB-E990-45AF-8DCE-4900DF811EE1Q35008383-06D22418-4B9C-4197-B871-689BCE3A170DQ35042726-C53387A4-25D5-42D7-8842-33E5873D8343Q35839545-A71E2D07-4E04-4475-81BB-1EBA120E7B15Q35864850-E1E63922-52DF-4B1D-B7AA-D4D4F1713E3DQ35981667-3C3EB299-16E0-4C24-B468-E4A0DFAE506BQ36083735-CA8A3221-DDED-4CCA-9A92-723D9C924477Q36654882-A3E5B38A-4C77-4F7F-BA86-BFA7DC02EC03Q36801655-CC9A0EBF-11F9-403F-A366-E646199B089AQ37379473-76E6B8D4-4FFB-48F6-9B65-8A439C7867BCQ37513377-0CD3525D-C75E-49FD-B557-96D656BD8583Q37547125-BAFCE63D-BD0E-4D18-AA4C-93999A40C163Q37598422-87CD8412-52DE-4BB3-B6F0-A4348DE98F71Q37954112-FAEE0BA2-CEFB-4A75-A79B-E87A634012D3Q38091648-388F7324-F78A-420F-9623-F51ECA1A6864Q38203865-66BB7D87-E6D3-475C-8040-0173EADCAEF3Q38258251-7F18D3B3-000D-48D6-8F00-766016D225EBQ38820033-CCA31847-20EA-40A1-B2E7-B095471FB213Q38820849-1B2E0A88-A6C7-4B23-BF44-8FE23522B94FQ38871403-EF9B2AE8-296B-4B5C-BCF4-BEAA2CBF4BD3Q39129176-CA36F359-3AD1-4B28-91AC-FDE0D0F33920Q40233317-42F9DBE2-8E61-487A-94A6-292E7E527442Q40355162-9424F465-8CA6-41A3-B0BA-1C3938B208DFQ40867858-15C89653-AD5B-4316-A81C-FBB65B6089A0Q40965247-F036690B-F8E5-4420-BD42-4A3B8D04A891Q41153418-A6B6452F-2D4B-4A66-88BC-47D0CD042AD8Q42028997-2D2ED762-9681-4003-8B52-B67A93E03C64Q42175474-0A75B65C-3257-46E4-A44A-6D60E1CD1C74
P2860
Opportunities for use of human iPS cells in predictive toxicology
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Opportunities for use of human iPS cells in predictive toxicology
@ast
Opportunities for use of human iPS cells in predictive toxicology
@en
type
label
Opportunities for use of human iPS cells in predictive toxicology
@ast
Opportunities for use of human iPS cells in predictive toxicology
@en
prefLabel
Opportunities for use of human iPS cells in predictive toxicology
@ast
Opportunities for use of human iPS cells in predictive toxicology
@en
P2093
P2860
P356
P1476
Opportunities for use of human iPS cells in predictive toxicology
@en
P2093
P2860
P304
P356
10.1038/CLPT.2011.9
P407
P577
2011-03-23T00:00:00Z